Global Human Genetics Market Size, Share, Forecast Report, 2020-2027

Genetics is nothing but the study of genes, their functions and effects. Molecular genetics, developmental genetics, population genetics and quantitative genetics, and human genetics are various types of genetic studies. Human genetics is the study of inheritance in human beings, i.e., it is the study of inheritance of characteristics in children from parents. It includes the study of gene expression, gene structure, mutation analysis, cytogenetics and genomic imaging, genome structure and organization, genetic and physical mapping, disease association studies, molecular diagnostics, genetics of complex diseases, epistatic interactions, and various other concepts. It also helps to determine various genetic factors responsible for diseases. It offers various advantages such as identification and diagnosis and treatment of various diseases such as cancer, cardiovascular diseases, and other genetic diseases.

The global human genetics market is driven by the increasing number of patients with genetic diseases and increasing healthcare expenditure by major economies across the globe. Furthermore, the growing awareness about genetic diseases, increasing investments in research and development, and rising government support fuel the market growth. However, various factors restrain the growth of the market such as higher cost of instruments and lack of skilled professionals.
Segmentation

The global human genetics market is segmented by instruments, methods, applications, and end-users.

On the basis of instruments, it is segmented into accessories and devices.

On the basis of methods, it is segmented into prenatal, molecular, cytogenetic, and presymptomatic.

On the basis of applications, it is segmented into forensic research, cancer, cardiovascular diseases, diabetes, genetic diseases, and others.

On the basis of end-users, it is segmented into hospitals, forensic laboratories, research centers, and others.

Key players

Some of the major players in the global human genetics market are Agilent Technologies (U.S.), Bode Technology (U.S.), GE Healthcare (U.K.), Illumina (U.S.), LGC Forensics (U.K.), Orchid Cellmark, Inc. (U.S.), Promega Corporation (U.S.), QIAGEN N.V. (Netherlands), and Thermo Fisher Scientific, Inc. (U.S.).